-
In just six months of operation, the congestive heart failure disease management program at Horizon/Mercy has resulted in few hospital admissions for some patients.
-
To get, on their own, the information that Pittsburgh-based Highmark Blue Cross Blue Shields SMART Registry provides them, physicians would have to conduct extensive and time-consuming chart reviews.
-
Highmark Blue Cross Blue Shield combined its previously disjointed disease management programs into an integrated condition management program that focuses on reducing the variations in effective care for five common conditions.
-
The Commission on Case Manager Certification (CCMC) in Rolling Meadows, IL, is opening nominations to fill four commission seats. Commission candidates are self-nominated. The deadline for submitting nominations is March 15.
-
The lack of a final HIPAA security regulation means that your organization doesnt have to provide security for your patient data, right? Wrong, according to a new handbook published by URAC. Your organization already has to protect patient data under the Health Insurance Portability and Accountability Act (HIPAA) privacy rule, the book points out.
-
Despite embracing technology in many aspects of their everyday lives, people are conflicted about the impact of information technology on their health care, according to a new survey.
-
Will your facility soon be implementing the OraQuick Rapid HIV-1 Antibody Test? If so, there are several resources to help you get up to speed in offering this new service.
-
While U.S. abortion rates are dropping, particularly among teens, the decline is not equally shared among all women. Rates have increased among those who are economically disadvantaged, according to just-published research from the New York City-based Alan Guttmacher Institute (AGI).
-
Get set to add more generic oral contraceptives (OCs) to your list of available birth control options as Corona, CA-based Watson Pharmaceuticals is rolling out its brand equivalents of Ortho-Cyclen and Ortho-Novum 7/7/7, two popular pills originally developed by Raritan, NJ-based Ortho-McNeil Pharmaceutical.
-
Put syphilis detection on your radar screen: Overall rates of primary and secondary syphilis have increased slightly for the first time in more than a decade, according to a new report from the Atlanta-based Centers for Disease Control and Prevention (CDC).1
